Company Registration Number 12439640 (England and Wales)
PHARMA SUPPLY CHAIN EXCELLENCE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023
PAGES FOR FILING WITH REGISTRAR
PHARMA SUPPLY CHAIN EXCELLENCE LTD
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF PHARMA SUPPLY CHAIN EXCELLENCE LTD FOR THE YEAR ENDED 28 FEBRUARY 2023
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Pharma Supply Chain Excellence Ltd for the year ended 28 February 2023, which comprise the balance sheet, from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/members/regulations-standards-and-guidance/.

This report is made solely to the board of directors of Pharma Supply Chain Excellence Ltd, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Pharma Supply Chain Excellence Ltd and state those matters that we have agreed to state to the board of directors of Pharma Supply Chain Excellence Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pharma Supply Chain Excellence Ltd and its board of directors as a body, for our work or for this report.

It is your duty to ensure that Pharma Supply Chain Excellence Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Pharma Supply Chain Excellence Ltd. You consider that Pharma Supply Chain Excellence Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Pharma Supply Chain Excellence Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Carpenter Box
4 October 2023
Chartered Accountants
Amelia House
Crescent Road
Worthing
West Sussex
BN11 1RL
PHARMA SUPPLY CHAIN EXCELLENCE LTD
BALANCE SHEET
AS AT 28 FEBRUARY 2023
28 February 2023
- 2 -
2023
2022
£
£
£
£
Fixed assets
-
0
501
Current assets
236,132
140,674
Prepayments and accrued income
479
459
Creditors: amounts falling due within one year
(44,963)
(30,379)
Net current assets
191,648
110,754
Total assets less current liabilities
191,648
111,255
Net assets
191,648
111,255
Capital and reserves
191,648
111,255
Notes to the financial statements
1
Employees

The average number of persons (including directors) employed by the company during the year was 2 (2022 - 2).

Pharma Supply Chain Excellence Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Amelia House, Crescent Road, Worthing, West Sussex, BN11 1RL.

For the year ended 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 4 October 2023 and are signed on its behalf by:
Mr I R Anderson
Director
Company Registration Number 12439640
2023-02-282022-03-01falseCCH SoftwareCCH Accounts Production 2023.200No description of principal activityMr I R AndersonMrs D A Anderson124396402022-03-012023-02-28124396402023-02-28124396402022-02-2812439640core:CurrentFinancialInstrumentscore:WithinOneYear2023-02-2812439640core:CurrentFinancialInstrumentscore:WithinOneYear2022-02-28124396402021-03-012022-02-2812439640bus:Director12022-03-012023-02-2812439640bus:PrivateLimitedCompanyLtd2022-03-012023-02-2812439640bus:SmallCompaniesRegimeForAccounts2022-03-012023-02-2812439640bus:Micro-entities2022-03-012023-02-2812439640bus:AuditExemptWithAccountantsReport2022-03-012023-02-2812439640bus:Director22022-03-012023-02-2812439640bus:FullAccounts2022-03-012023-02-28xbrli:purexbrli:sharesiso4217:GBP